Capiibine 500MG Tablet (30’s) is a prescription medication that contains Capecitabine, a chemotherapeutic agent primarily used in the treatment of various types of cancer, including colorectal and breast cancer. Each tablet contains 500 mg of Capecitabine, which is an oral prodrug that is converted into the active form, 5-fluorouracil (5-FU), in the body. This conversion occurs mainly in tumor tissues, allowing for targeted cancer treatment while minimizing damage to healthy cells. Capiibine is designed to inhibit DNA synthesis and cell division in cancer cells, thereby slowing down or stopping tumor growth. It is often prescribed as part of a combination therapy to enhance its effectiveness against cancer. Patients taking Capiibine should be closely monitored for side effects and therapeutic efficacy, making it essential for healthcare providers to tailor treatment plans based on individual patient needs.

Cacit 500MG Tablet (10’s) is a pharmaceutical product that contains Capecitabine as its active ingredient, with each tablet delivering a potent dose of 500mg. This medication is primarily utilized in the treatment of various types of cancer, particularly colorectal and breast cancer, where it serves as an effective chemotherapeutic agent. Capecitabine is an oral prodrug that is converted into 5-fluorouracil (5-FU) in the body, which is a well-known antimetabolite that disrupts the growth of cancer cells. The formulation of Cacit 500MG Tablet is designed to provide a convenient oral option for patients undergoing cancer treatment, allowing for easier administration compared to intravenous therapies. The drug works by interfering with the synthesis of DNA and RNA, ultimately leading to the death of rapidly dividing cancer cells. As a result, Cacit 500MG Tablet plays a crucial role in the management of cancer, contributing to improved patient outcomes and quality of life.